.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The SOLO1 trial evaluated maintenance olaparib in women with newly diagnosed advanced ovarian cancer carrying BRCA1 or BRCA2 mutations who had responded to platinum-based chemotherapy. Olaparib produced a major improvement in progression-free survival compared with placebo. The study established a new treatment paradigm in ovarian cancer in which molecular biomarkers influence maintenance therapy after initial response. For gynecologic oncologists, this means germline and tumor genetic testing can directly affect treatment planning. Counseling should include discussion of hereditary cancer implications, family testing and the long-term management of therapy-related adverse effects. The broader clinical message is that precision oncology depends on timely biomarker identification and integration of molecular results into the treatment pathway rather than using targeted therapies only after multiple lines of chemotherapy.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The SOLO1 trial evaluated maintenance olaparib in women with newly diagnosed advanced ovarian cancer carrying BRCA1 or BRCA2 mutations who had responded to platinum-based chemotherapy. Olaparib produced a major improvement in progression-free survival compared with placebo. The study established a new treatment paradigm in ovarian cancer in which molecular biomarkers influence maintenance therapy after initial response. For gynecologic oncologists, this means germline and tumor genetic testing can directly affect treatment planning. Counseling should include discussion of hereditary cancer implications, family testing and the long-term management of therapy-related adverse effects. The broader clinical message is that precision oncology depends on timely biomarker identification and integration of molecular results into the treatment pathway rather than using targeted therapies only after multiple lines of chemotherapy.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
4 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
5 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back
